Cargando…

Verteporfin inhibits growth of human glioma in vitro without light activation

Verteporfin (VP), a light-activated drug used in photodynamic therapy for the treatment of choroidal neovascular membranes, has also been shown to be an effective inhibitor of malignant cells. Recently, studies have demonstrated that, even without photo-activation, VP may still inhibit certain tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Moujahed, Ahmad, Brodowska, Katarzyna, Stryjewski, Tomasz P., Efstathiou, Nikolaos E., Vasilikos, Ioannis, Cichy, Joanna, Miller, Joan W., Gragoudas, Evangelos, Vavvas, Demetrios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548915/ https://www.ncbi.nlm.nih.gov/pubmed/28790340 http://dx.doi.org/10.1038/s41598-017-07632-8

Ejemplares similares

Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
por: Konstantinou, Eleni K., et al.
Publicado: (2017)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis
por: Theodoropoulou, Sofia, et al.
Publicado: (2013)

Effects of metformin on retinoblastoma growth in vitro and in vivo
por: BRODOWSKA, KATARZYNA, et al.
Publicado: (2014)

Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through modulating cell cycle progression genes
por: Al-Moujahed, Ahmad, et al.
Publicado: (2019)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration
por: Kosmidou, Cassandra, et al.
Publicado: (2018)

Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization
por: Salehi-Had, Hani, et al.
Publicado: (2011)

Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation
por: Chen, Min, et al.
Publicado: (2017)

Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation
por: Wei, Changran, et al.
Publicado: (2020)

AICAR suppresses TNF-α-induced complement factor B in RPE cells
por: Chung, Eun Jee, et al.
Publicado: (2017)

Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells
por: Tian, Bo, et al.
Publicado: (2017)

EGF-Like-Domain-7 Is Required for VEGF-Induced Akt/ERK Activation and Vascular Tube Formation in an Ex Vivo Angiogenesis Assay
por: Takeuchi, Kimio, et al.
Publicado: (2014)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)

Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment
por: Vavvas, Demetrios G., et al.
Publicado: (2016)

Docking analysis of verteporfin with YAP WW domain
por: Kandoussi, Ilham, et al.
Publicado: (2017)

Verteporfin as a Medical Treatment in Peyronie’s Disease
por: Mohede, Daan C.J., et al.
Publicado: (2018)

The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
por: Wei, Changran, et al.
Publicado: (2020)

Dramatic Reduction of Distant Pancreatic Metastases Using Local Light Activation of Verteporfin with Nab-Paclitaxel
por: Pigula, Michael, et al.
Publicado: (2021)

AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages
por: Kumase, Fumiaki, et al.
Publicado: (2016)

Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
por: Eales, Katherine L., et al.
Publicado: (2018)

Acadesine suppresses TNF-α induced complement component 3 (C3), in retinal pigment epithelial (RPE) cells
por: Efstathiou, Nikolaos E., et al.
Publicado: (2020)

Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins
por: Fote, Gianna M., et al.
Publicado: (2022)

RIP Kinase-Mediated Necrosis as an Alternative Mechanism of Photoreceptor Death
por: Murakami, Yusuke, et al.
Publicado: (2011)

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
por: Matsumoto, Hidetaka, et al.
Publicado: (2013)

Advances in Age-related Macular Degeneration Understanding and Therapy
por: Miller, Joan W, et al.
Publicado: (2017)

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020)

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim, Shaheen P, et al.
Publicado: (2013)

Differential gene expression induced by Verteporfin in endometrial cancer cells
por: Bang, Lisa Gahyun, et al.
Publicado: (2019)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
por: Sirks, Marc J., et al.
Publicado: (2022)

Checkpoint inhibitor-induced sarcoid choroidal granulomas
por: Ung, Cindy, et al.
Publicado: (2020)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Systematic Review
por: Lin, Jonathan B., et al.
Publicado: (2022)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
por: Lin, Jonathan B., et al.
Publicado: (2022)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma
por: Lui, Jason W., et al.
Publicado: (2019)

Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rocarqtf2l8ns47efm3aiqkb2v